Clinical trial

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

NCT02087579

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Aripiprazole, oral formulation Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Olanzapine, oral formulation Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Paliperidone, oral formulation Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Paliperidone, LAI Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Quetiapine, oral formulation Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Risperidone, oral formulation Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Risperidone, LAI Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-02-01

PhasePHASE1

Conditions

Psychotic Disordersunresolved

Schizophreniaverified · MONDO: schizophrenia

Bipolar Disorderverified · MONDO: bipolar disorder

Depressive Disorderverified · MONDO: depressive disorder

Interventions

Aripiprazole, oral formulationDRUG

Olanzapine, oral formulationDRUG

Paliperidone, oral formulationDRUG

Paliperidone, LAIDRUG

Quetiapine, oral formulationDRUG

Risperidone, oral formulationDRUG

Risperidone, LAIDRUG

Sponsors & collaborators

Janssen Research & Development, LLClead sponsor

Mapped research locations

AtlantaGeorgia, United States1 BarcelonaSpain1 BerlinGermany1 AustinTexas, United States1 HamburgGermany1 BrusselsBelgium1 Buenos AiresArgentina1 Rio de JaneiroBrazil1 CórdobaArgentina1 Garden GroveCalifornia, United States1 AntwerpBelgium1 LübeckGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02087579 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.